Cytodyn Inc (CYDY)

[Leronlimab4DaWin]

$500mm valuation is INSANE.

The HIV product, if approved, is MAYBE worth $50mm to a partner (that market is very small and already many approved drugs). There’s no way Cytoshit could build out a sales team to sell this snake oil HIV drug vs other players so they’d have to sell it or watch it be a commercial flop.

The NASH/TNBC/etc are just dumb pipe dreams that cost a ton of money to run trials, that they don’t have, and are worth zero. Most pipe dreams are valued at zero in biotech.

The COVID therapeutic indication we see today is worth zero

The long haulers is a joke. It failed all covid trials but it’ll work for long haulers? LOL! Also, there’s some actual nefarious activity happening, per the FDA, by these trial doctors who are advertising results while also leading the trial sites (FDA may fine Gaylis and Reckor and could pull trial sites).

So what are you left with?

$50mm HIV drug that still needs to submit BLA by YE, $75mm total payable to Samsung, and lord knows how much they owe Fife + Fife lawsuits (last lawsuit netted him $22.5mm in stock), then there’s carrying costs / operation expenses. All in this is most likely a BK in the next 6-12m. With fife crushing the stock with his ratchet before then